These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8182921)

  • 41. [Clinical pharmacology of idarubicin].
    Robak T
    Acta Haematol Pol; 1993; 24(4):315-26. PubMed ID: 8303977
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of drug resistance is reduced with idarubicin relative to other anthracyclines.
    Hargrave RM; Davey MW; Davey RA; Kidman AD
    Anticancer Drugs; 1995 Jun; 6(3):432-7. PubMed ID: 7670142
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p170-dependent multidrug resistance. Restoring full sensitivity to idarubicin with verapamil and cyclosporin A derivatives.
    Michieli M; Damiani D; Michelutti A; Melli C; Russo D; Fanin R; Baccarani M
    Haematologica; 1994; 79(2):119-26. PubMed ID: 7914881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative pharmacokinetic study of idarubicin and daunorubicin in leukemia patients.
    Robert J; Rigal-Huguet F; Hurteloup P
    Hematol Oncol; 1992; 10(2):111-6. PubMed ID: 1592361
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo uptake of daunorubicin by acute myeloid leukemia (AML) cells measured by flow cytometry.
    Kokenberg E; Sonneveld P; Delwel R; Sizoo W; Hagenbeek A; Löwenberg B
    Leukemia; 1988 Aug; 2(8):511-7. PubMed ID: 3166077
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of verapamil on the cellular accumulation of daunorubicin in blast cells and on the chemosensitivity of leukaemic blast progenitors in acute myelogenous leukaemia.
    Maruyama Y; Murohashi I; Nara N; Aoki N
    Br J Haematol; 1989 Jul; 72(3):357-62. PubMed ID: 2765404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anthracycline drugs and MDR expression in human leukemia.
    Pogliani EM; Belotti D; Rivolta GF; Maffè PF; Corneo G
    Cytotechnology; 1996; 19(3):229-35. PubMed ID: 8862011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multidrug reverting activity toward leukemia cells in a group of new verapamil analogues with low cardiovascular activity.
    Biscardi M; Teodori E; Caporale R; Budriesi R; Balestri F; Scappini B; Gavazzi S; Grossi A
    Leuk Res; 2006 Jan; 30(1):1-8. PubMed ID: 16061283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison between anthracyclines and rhodamine-123 accumulation in chronic lymphoid leukemia: effect of cyclosporin A and verapamil.
    Maia RC; Vasconcelos FC; Harab RC; Coelho AM; Dobbin JA; Rumjanek VM
    Tumour Biol; 1998; 19(1):41-51. PubMed ID: 9422081
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sensitivities of AML blast stem cells to idarubicin and daunorubicin: a comparison with normal hematopoietic progenitors.
    Curtis JE; Minden MD; Minkin S; McCulloch EA
    Leukemia; 1995 Mar; 9(3):396-404. PubMed ID: 7533865
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multidrug resistance modulation in vivo: the effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia.
    Pea F; Damiani D; Michieli M; Ermacora A; Baraldo M; Russo D; Fanin R; Baccarani M; Furlanut M
    Eur J Clin Pharmacol; 1999 Jul; 55(5):361-8. PubMed ID: 10456485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of verapamil on daunorubicin accumulation in human leukemic cells with different levels of MDR1 gene expression.
    Gruber A; Briese B; Areström I; Vitols S; Björkholm M; Peterson C
    Leuk Res; 1993 Apr; 17(4):353-8. PubMed ID: 8487584
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Altered intracellular distribution of daunorubicin in immature acute myeloid leukemia cells.
    Lautier D; Bailly JD; Demur C; Herbert JM; Bousquet C; Laurent G
    Int J Cancer; 1997 Apr; 71(2):292-9. PubMed ID: 9139856
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclosporin increases cellular idarubicin and idarubicinol concentrations in relapsed or refractory AML mainly due to reduced systemic clearance.
    Smeets M; Raymakers R; Muus P; Vierwinden G; Linssen P; Masereeuw R; de Witte T
    Leukemia; 2001 Jan; 15(1):80-8. PubMed ID: 11243404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Study of apoptosis-related responses of leukemic blast cells to in vitro anthracycline treatment.
    Belaud-Rotureau MA; Durrieu F; Labroille G; Lacombe F; Fitoussi O; Agape P; Marit G; Reiffers J; Belloc F
    Leukemia; 2000 Jul; 14(7):1266-75. PubMed ID: 10914552
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative activity of idarubicin and idarubicinol in combination with cyclosporin A in multidrug-resistant leukemia cells.
    Tolomeo M; Gancitano RA; Musso M; Porretto F; Perricone R; Abbadessa V; Cajozzo A
    Cancer Chemother Pharmacol; 1996; 39(1-2):157-61. PubMed ID: 8995514
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of mechanisms responsible for resistance to idarubicin and daunorubicin in multidrug resistant LoVo cell lines.
    Toffoli G; Simone F; Gigante M; Boiocchi M
    Biochem Pharmacol; 1994 Nov; 48(10):1871-81. PubMed ID: 7986198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of daunorubicin intracellular accumulation in P-glycoprotein expressing MCF-7 human breast adenocarcinoma cells by thermosensitive-liposome encapsulation and hyperthermia.
    Merlin JL; Marchal S; Ramacci C; Notter D; Vigneron C
    Int J Hyperthermia; 1995; 11(6):855-65. PubMed ID: 8586906
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circumvention of daunorubicin resistance by a new tamoxifen derivative, toremifene, in multidrug-resistant cell line.
    Urasaki Y; Ueda T; Nakamura T
    Jpn J Cancer Res; 1994 Jun; 85(6):659-64. PubMed ID: 7914886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Daunorubicin uptake by leukemic cells: correlations with treatment outcome and mdr1 expression.
    Marie JP; Faussat-Suberville AM; Zhou D; Zittoun R
    Leukemia; 1993 Jun; 7(6):825-31. PubMed ID: 8099135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.